EU and USA Harmonisation of Content and Message Exchange for IDMP Implementation Vada A. Perkins

HL7 Structured Product Labeling (SPL) specification as enabler of EU/US exchange of medicinal product information

HL7 SPL(R7) Publication HL7 SPL(R7) Publication: To be submitted by this Friday (ballot approved) SPL Release 7 as the data exchange format to support ISO IDMP Technical Specifications. The ISO IDMP Technical Specifications describes the data exchange for the five (5) ISO International Standards Incorporates European Union (EU)/European Medicines Agency (EMA) requirements for EU implementation of the five IDMP standards utilizing HL7 SPL to support their legislative requirements for product registration and pharmacovigilance. – 92 data elements – SmPC requirements

ISO IDMP Normative Standard e-Message for Data Exchange: Common Product Model (CPM) The Health Level Seven (HL7) Common Product Model (CPM) provides: Overarching information model Reusable Common Message Element Types (CMETs) Consistent data types and conformance rules Vocabulary domains Schemas for data exchange

Style Sheet View/Source Code (XML) 5

FDA Relevant “SPOR” Registrant – Contact – Address – Telephone number – address Establishment/Facility – Name (business) – Contact – Address – Telephone number – address – ID (DUNS, FDA ID, EMA/EU ID) – Business Operations – GPS coordinates Importer – Contact – Address – Telephone number – address – ID (DUNS, FDA ID, EMA/EU ID) – GPS coordinates In Country Contact (e.g., US Agent) – Name (business) – Contact – Address – Telephone number – address – (DUNS, FDA ID, EMA/EU, ID)

EMA/EU Data Elements 7 Around 20 data elements were removed/ streamlined/ re-modelled → 74 Data elements in PMS Iteration 1 If it is agreed to include 5 data elements to cover Shortage and Marketing information → Total 79 Data elements in PMS Iteration 1

Language/Code and the section: Description Goodmedicine is a white to off-white powder...

Link to the Original Source of Translation

Package and Submission of Multiple Translations When required, each SPL file (having one language) should be packaged in its own folder. The name of the folder may contain the language code

Implementing IDMP: The Pivotal Role of the PhPID (Pharmaceutical Product Identification)

Paracetamol (aka acetaminophen) 12

Paracetamol/Acetaminophen PhPID_SUB_L1  paracetamol PhPID_SUB_L2  paracetamol, 1000 mg PhPID_ SUB _L3  paracetamol, tablet PhPID_ SUB _L4  paracetamol, 1000 mg, tablet PhPID_SUB_L1  paracetamol PhPID_SUB_L2  paracetamol, 500 mg PhPID_ SUB _L3  paracetamol, capsule PhPID_ SUB _L4  paracetamol, 500 mg, capsule PhPID_SUB_L1  paracetamol PhPID_SUB_L2  paracetamol, 750 mg PhPID_ SUB _L3  paracetamol, tablet- film coated PhPID_ SUB _L4  paracetamol, 750 mg, tablet-film coated 13

Substa nce ID Dose form Strength Input Output Substa nce ID Strength Substance 1 Substance 2 ・・・ Substance n MD5 digestion PhPID code (example) 128 bit (16 byte) number which, in hexadecimal presentation, is 32 digits long formatted in groups of digits separated by hyphens -Globally Unique Identifier (GUID) NCI thesaurus code UNII code Normalized unit UNII code Normalized unit Alphabetic order of UNII code MD5 is a widely used algorithm for hash function. FDA algorithm (beta) for PhPID Generation 14

15 ISO “SPOR”: Global Harmoni(sz)ation Medicinal Product ID (MPID) ▫ Regional Identification Pharmaceutical Product ID (PhPID) ▫ IDMP (algorithm) ▫ Based on core elements for identification of medicinal products ▫ Demands harmonization of terminologies/IDs for globally unique identification (internal and external to EU). Substances ▫ Global Substance Registration System (G-SRS) ▫ EMA/EU-FDA Bilateral (governance) Units of measurement ▫ Unified Code for Units of Measure (UCUM) Dosage forms-mapping exercise (ongoing) European Directorate for the Quality of Medicines (EDQM)

Policy Pathways to Implementing IDMP in the US (FDA) OpenMedicine 20 June2016 Mary Ann Slack (CDER) Vada A. Perkins (CBER) 16

Terminology alignment Finalisation of EU Implementation Guides (EU IGs) Expand and manage content (based on Iterations) Build technical services Initial organisation dictionary Build technical services Controlled vocabularies for IDMP Finalisation of ISO documentation (standards review and Technical Specifications) O R P S Q1/Q Enforcement of Product & Substance Iteration 1 Kick off Product & Substance Iteration 1 Transition Phase Preparation Phase Product & Substance Pre-Submission Terminology alignment Registration of new terms Expand and manage content Implementation of initial electronic submission Preparation for electronic submission Terminology alignment (continuation) Q1/Q Q3/Q Maintenance Phase Product & Substance Submission Overall high level plan for SPOR (updated) Legal deadlinePublication of EU IGs July 2016 Q3/Q4 2016

Why Implement IDMP? FDA needs to be able to organize and “connect” relevant data to support both pre-market and post-market activities FDA and other regulatory authorities need to share information to aid in safety and compliance activities Example: identifying global drug safety issues Product information must be consistently described to be understandable across regional boundaries A common exchange structure enables sharing critical data Medicinal product identification and SPL enable this organizing and sharing this data 18

How Might FDA Implement IDMP? Through regulation Through guidance With the enactment of FDASIA in 2012, through “binding” guidance 19

What is a Statute? A statute is a law passed by the U.S. Congress Examples: Food, Drug and Cosmetic Act, 1938 (established what is now the U.S. FDA) Food and Drug Administration Science and Innovation Act (FDASIA),

What is a Regulation? A rule issued by FDA consistent with U.S. law, published in the U.S. Federal Register and contained in the Code of Federal Regulations (CFR) Functions of regulations: 21 Protect patients from harmful medical products Facilitate the availability of beneficial medical products to patients

What is U.S. FDA Guidance? FDA’s current thinking on how to comply with a particular statutory, regulatory requirement or issue A guidance, unlike a statute or regulation, does not establish “legally enforceable rights or responsibilities” and do not bind the public or FDA Generally, guidance is prepared by FDA staff 22

23 When Does FDA Issue Guidance? To announce its interpretation of a statutory or regulatory requirement for the 1 st time. When guidance is required by a statute. When guidance is useful to explain how to implement a statute or regulation. When guidance would provide more transparency and clarity in its scientific thinking. When the “current thinking” changes.

Congress authorized FDA to implement statutory electronic submission requirements by specifying the format for such submissions in guidance Section 745A(a) – Drugs and Biologics –Applies to all submissions for INDs, NDAs, ANDAs and BLAs, including supplements, DMFs, and drug/device combination products –Noncommercial IND exemption Unlike our usual ‘Guidance for Industry’ documents, this guidance is binding. 24 Food and Drug Administration Safety and Innovation Act, July 2012

FDA Safety and Innovation Act (FDASIA) Section 1136 of FDASIA (Jul 9, 2012) amended the FD&C Act by adding new section 745A, which addresses electronic submissions. Starting 24 months after final guidance for a specific submission type, Sponsors must use the standards defined in the data standards catalog (for submissions for NDAs, ANDAs, and BLAs). 25 Guidance document for Submissions Under Section 745A(a): –Effective date: December 2016 (CDISC: SDTM) –Effective date: May 2017 (e-CTD)

26 24 Months after Final Guidance Individual Guidances NDAs, ANDAs, BLAs, INDs Timetable Content Format How may required eSubmissions be Implemented?

FDASIA Guidance Implementation Highlights 27

In Summary FDA is working to implement IDMP internally Pathways exist for recommending or requiring standardized electronic submission of IDMP data If FDA determines that the best path is to require standardized electronic submissions, that requirement would be a minimum of 24 months after final guidance is issued. 28

US FDA IDMP Roadmap ** US FDA Content of Labeling GDUFA Self-ID of Facilities, Sites, Organization Transition phase to ISO IDMP Publication HL7 Establishment Registration/Drug Product Listing Paper to Electronic Submission (HL7 CPM/SPL, eCTD) ISO Publication of ISO IDMP Standards ISO IDMP New Work Item (NWI) Proposals LDD, WDD/3PL, 3911 HL7 V3 (Normative to ISO IDMP) SPL Indexing SPL(R6) &(R7)/ CPM (R2) &(R3) IDMP TS/Standards Revision (5 year cycle) SPL (R2) 2007 SPL (R3) SPL (R4) SPL(R5) / SPL (R1) FR Notice/ Guidance (Draft) **US FDA SPL Implementation Guide (technical specification) updated with corresponding Guidance for Industry (incorporated by reference) Reference: Vada Perkins ISO /FDA IDMP Topic Lead/Expert 29

FDA Implemented (IDMP/SPL) 30

Global Identification of Medicinal Products (IDMP) Lifecycle SPORSPOR